Matthew Shair

Director

Matthew Shair (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $6.0M of NUVL (60,000 sh across 4 lots, as filed), executed Oct 27 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.6M

shares × price, as filed

Last traded

Nov 24 2025

Filed Nov 26 2025

Median ADV $288.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $6.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

NUVL

Nuvalent Inc NUVL · 0 buys · 6 sells 6 filings

Recent filings

NUVLSALE Nuvalent Inc View filing → $600K
5,481 sh across 3 lots
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $6.0M
60,000 sh across 4 lots
Exec Oct 27 2025
Filed Oct 29 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $108K
1,382 sh × $78.49
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $118K
1,409 sh × $83.62
Exec Dec 23 2024
Filed Dec 26 2024 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $108K
1,181 sh × $91.31
Exec Oct 28 2024
Filed Oct 30 2024 · 5:30 PM ET NUVLSALE Nuvalent Inc View filing → $115K
1,121 sh × $102.29
Exec Sep 23 2024
Filed Sep 25 2024 · 5:30 PM ET